{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:47:26Z","timestamp":1777355246738,"version":"3.51.4"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00107","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:31:23Z","timestamp":1553733083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A Novel Mutation in Chronic Granulomatous Disease: Treating the Family, Not Just the Patient"],"prefix":"10.3389","volume":"7","author":[{"given":"Kristen","family":"Lutzkanin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"McKeone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doerthe Adriana","family":"Andreae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"key":"B1","author":"Leiding","year":"1993","journal-title":"Chronic Granulomatous Disease."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","article-title":"Common severe infections in chronic granulomatous disease","volume":"60","author":"Marciano","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0161-5890(98)90515-6","article-title":"Chronic granulomatous disease; report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bcmd.2010.07.012","article-title":"Hematologically important mutations: X-linked chronic granulomatous disease (third update)","volume":"45","author":"Roos","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","article-title":"Genetic, biochemical, and clinical features of chronic granulomatous disease","volume":"79","author":"Segal","year":"2000","journal-title":"Medicine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1182\/blood-2009-07-231498","article-title":"A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity","volume":"114","author":"Matute","year":"2009","journal-title":"Blood."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1038\/s41467-018-06964-x","article-title":"A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease","volume":"9","author":"Arnadottir","year":"2018","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2249.2008.03644.x","article-title":"Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry","volume":"152","author":"Jones","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","article-title":"Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: An Italian multicenter study","volume":"126","author":"Martire","year":"2008","journal-title":"Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e5234","DOI":"10.1371\/journal.pone.0005234","article-title":"Chronic granulomatous disease: the European experience","volume":"4","author":"van","year":"2009","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/01.inf.0000164761.81491.3f","article-title":"Invasive Chromobacterium violaceum infection in children: case report and review","volume":"24","author":"Sirinavin","year":"2005","journal-title":"Pediatr Infect Dis J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1126\/science.155.3764.835","article-title":"Leukocyte oxidase: defective activity in chronic granulomatous disease","volume":"155","author":"Baehner","year":"1967","journal-title":"Sci Am Assoc Adv Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1067\/mai.2003.58","article-title":"Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay","volume":"111","author":"Jirapongsananuruk","year":"2003","journal-title":"J Allergy Clin Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.anai.2016.07.008","article-title":"Chronic granulomatous disease as an SOS call for multicenter cooperative effort to prevent infections: A meta-analysis of the treatments","volume":"117","author":"Loffredo","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/moh.0000000000000097","article-title":"Chronic granulomatous disease \u2013 conventional treatment vs","volume":"22","author":"\u00c5hlin","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.bbmt.2012.02.002","article-title":"Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease","volume":"18","author":"Tewari","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study","volume":"383","author":"G\u00fcng\u00f6r","year":"2014","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.bbmt.2016.08.0131083-8791","article-title":"A single-center experience comparing alemtuzumab, fludarabine, and melphalan reduced-intensity conditioning with myeloablative busulfan, cyclophosphamide, and antithymocyte globulin for chronic granulomatous disease","volume":"22","author":"Khandelwal","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0140-6736(13)62144-3","article-title":"Stem-cell transplantation for chronic granulomatous disease","volume":"383","author":"Prasad","year":"2014","journal-title":"Lancet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s12325-017-0636-2","article-title":"A Review of Chronic Granulomatous Disease","volume":"34","author":"Arnold","year":"2017","journal-title":"Adv Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"13534","DOI":"10.1093\/nar\/gku1206","article-title":"In silico prediction of splice-altering single nucleotide variants in the human genome","volume":"42","author":"Jian","year":"2014","journal-title":"Nucl Acids Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/cei.12202","article-title":"Molecular diagnosis of chronic granulomatous disease","volume":"175","author":"Roos","year":"2014","journal-title":"Clin Exp Immunol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00107\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:31:24Z","timestamp":1553733084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00107\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":23,"alternative-id":["10.3389\/fped.2019.00107"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00107","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"article-number":"107"}}